Nā Koina Hana Lapaʻau Hou no ka maʻi diabetes

Anter

• Nā lāʻau hou no ka maʻi kō
• ʻO nā lāʻau waha hou
• Xigduo XR
• Synjardy
• ʻO Glyxambi
• ʻO Steglujan
• ʻO Segluromet
• ʻO Steglatro
• Mea hoʻopili hou
• Tresiba
• Basaglar lāua ʻo Toujeo
• Xultophy
• ʻO Soliqua
• Ozempic
• Adlyxin
• ʻO Ryzodeg
• Nā lāʻau diabetes i ka ulu ʻana
• Nā lāʻau lapaʻau diabetes maʻamau i hoʻohana mau ʻia
• Nā lāʻau lapaʻau waha
• ʻO Biguanides e like me metformin
• Nā mea kāpae Alpha-glucosidase
• Dipeptidyl peptidase-4 mea kāohi (DPP-IV nā mea kūpale)
• ʻO Meglitinides
• Sodium-glucose co-transporter 2 mea kāohi (SGLT2)
• Sulfonylureas
• ʻO Thiazolidinediones
• Hoʻohui lāʻau
• Nā lāʻau hoʻōki
• Insulina
• Amylin analogue
• Glucagon-like peptide-1 receptor agonists (GLP-1 agonists)
• Nā mea e noʻonoʻo ai i ke koho ʻana i kahi lāʻau

I Mei 2020, ua paipai ʻia i kekahi mau mea hana o metformin hoʻolōʻihi hoʻokuʻu ʻia e kāpae i kekahi o kā lākou papa mai ka mākeke U.S. ʻO kēia no ka mea he pae i ʻae ʻole ʻia o kahi carcinogen probable (ʻākena e hana ana i ka maʻi ʻaʻai) i loaʻa i kekahi mau papa metformin hoʻolōʻihi ʻia. Inā lawe ʻoe i kēia lāʻau i kēia manawa, e kāhea i kāu kauka. E ʻōlelo aʻoaʻo lākou inā ʻoe e hoʻomau i ka lawe ʻana i kāu lāʻau a i ʻole inā makemake ʻoe i kahi palapala hou.

Ke loaʻa ʻoe i ka maʻi diabetes, pilikia kou kino i ka mālama ʻana i ka insulin. ʻO ka insulin ka mea i hana ʻia e kāu pancreas e kōkua ai i kou kino e hoʻohana i ka glucose (kō) mai ka meaʻai āu e ʻai ai. Hoʻoneʻe ka Insulin i ka glucose mai kou kahena i loko o kāu mau hunaola, e hoʻohana ai ia no ka ikehu. Akā inā ʻaʻole lawa kou kino i ka nui o ka insulin a hoʻohana ʻole paha ia mea maikaʻi, noho ka glucose i kou koko. ʻO ka loaʻa ʻana o nā kō glucose kiʻekiʻe no ka lōʻihi loa hiki ke hōʻino i nā ʻāpana o kou kino.

Aia ʻelua ʻano maʻi diabetes: ʻano 1 a ʻano 2. ʻAʻole hiki i ka poʻe me ka maʻi diabetes 1 ke hana i kā lākou iho insulin. Hiki i nā poʻe me ka maʻi diabetes type 2 ke hana i ka insulin, akā ʻaʻole hiki i ko lākou mau kino ke hoʻohana kūpono.

ʻOiai ʻo ka lāʻau wale nō i hoʻohana ʻia e mālama i ka poʻe me ka maʻi diabetes type 1 ka insulin, hele mai ia i nā ʻano like ʻole. ʻO ka poʻe me ka maʻi diabetes type 2, ma ka ʻaoʻao ʻē aʻe, loaʻa ka nui o nā koho lāʻau. I ka ʻoiaʻiʻo, pono paha lākou e lawe i hoʻokahi ʻano lāʻau aʻe e mālama ai i ko lākou kūlana.

E heluhelu aʻe e aʻo e pili ana i nā koho lāʻau kō diabetes hou a me nā lāʻau e hoʻomohala ʻia nei, a me nā lāʻau i hoʻohana mau ʻia no nā ʻano maʻi diabetes.

Nā lāʻau hou no ka maʻi kō

I nā makahiki i hala iho nei, ua hoʻomohala ʻia kekahi mau lāʻau diabetes. Hoʻopili kēia i nā lāʻau lae waha a me nā mea i hoʻokomo ʻia.

ʻO nā lāʻau waha hou

Koe wale no Steglatro, nona ka lāʻau hoʻokahi wale nō, ʻo nā lāʻau lapaʻau waha hou i hoʻohana ʻia e mālama ai i ka maʻi diabetes type 2 he lāʻau lapaʻau hui pū ʻia. Hoʻohui like lākou i ʻelua mau lāʻau i hoʻohana ʻia e mālama ai i ka maʻi diabetes type 2.

ʻO kēia mau lāʻau lapaʻau nā lāʻau a pau i ka inoa inoa ʻole i loaʻa ʻole nā ​​ʻano generic.

Xigduo XR

ʻO Xigduo XR, i hele mai ma ke ʻano he 24 hola ka lōʻihi o ka hoʻokuʻu waha, ʻae ʻia no ka hoʻohana ʻana ma 2014. Hoʻohui ʻo Xigduo XR i ka metformin me dapagliflozin Kōkua ʻo Metformin i nā kino o ke kino i maʻalahi i ka insulin. Paʻa ʻo Dapagliflozin i kekahi o nā glucose i kāu ʻōnaehana mai ke komo hou ʻana i kou koko ma o kou puʻupaʻa. Hoʻopau ia i kou kino e hoʻopau i nā glucose hou aʻe ma o kou mimi.

Synjardy

ʻO Synjardy, i hele mai ma ke ʻano he papa waha, ua ʻae ʻia no ka hoʻohana ʻana ma 2015. Hoʻohui ʻia nā lāʻau i metformin a me empagliflozin. Hana ʻo Empagliflozin i kahi ala like me dapagliflozin.

ʻO Glyxambi

ʻO Glyxambi, ʻo ia hoʻi kahi papa waha, i ʻae ʻia no ka hoʻohana ʻana ma 2015. Hoʻohui ʻia nā lāʻau lapaʻau linagliptin a me empagliflozin. Ua ālai ʻo Linagliptin i ka haki ʻana o kekahi mau hormones i loko o kou kino e haʻi i kāu pancreas e hana a hoʻokuʻu i ka insulin. Hoʻomaha ia i kāu digestion, kahi e lohi ai i ka hoʻokuʻu ʻia ʻana o ka glucose i loko o kou koko.

ʻO Steglujan

ʻO Steglujan, i hele mai ma ke ʻano he papa waha, ua ʻae ʻia i ka hopena o 2017. Hoʻohui ʻia ia ertugliflozin a me sitagliptin.

Hana ʻo Ertugliflozin ma o ka hana like me empagliflozin. Paʻa ʻo Sitagliptin i ka haki ʻana o kekahi mau hormones i kou kino e haʻi i kāu pancreas e hana a hoʻokuʻu i ka insulin. Hoʻomaha ia i kāu digestion, kahi e lohi ai i ka lawe ʻana o ka glucose i loko o kou koko.

ʻO Segluromet

ʻO Segluromet, i hele mai ma ke ʻano he papa waha, ua ʻae ʻia i ka hopena o 2017. Hoʻohui ʻia ia ertugliflozin a me metformin.

ʻO Steglatro

ʻO Steglatro, i hele mai ma ke ʻano he papa waha, ua ʻae ʻia i ka hopena o ka makahiki 2017. He inoa inoa inoa o ka lāʻau ertugliflozin. Hana ia ma o ka hana like me empagliflozin. E like me nā lāʻau hoʻohui i kēia papa inoa, hoʻohana ʻia ʻo Steglatro e mālama i ka maʻi diabetes type 2.

Mea hoʻopili hou

ʻAʻole loaʻa kēia mau inoa inoa inoa inoa inoa inoa inoa e like me nā lāʻau laulaha. Hoʻohana ʻia lākou e mālama i nā ʻano maʻi diabetes ʻelua, a i ʻole ʻelua a ʻelua a me ʻelua ʻano diabetes.

Loaʻa i kēia mau lāʻau lapaʻau kahi ʻano o ka insulin, kahi agonist GLP-1, a i ʻole ʻelua. ʻO nā ʻano ʻokoʻa o ka inikine i hōʻino ʻia e hana ma ke ʻano he pani no ka insulina a kou kino e hana a hiki ʻole ai ke hoʻohana kūpono. ʻO nā agonists reseptor like Glucagon-like peptide-1 (GLP-1) kōkua i kāu pancreas e hoʻokuʻu i ka nui o ka insulin ke kiʻekiʻe ke kiʻekiʻe o kāu glucose. Hoʻoiho lākou i ka lawe ʻana o ka glucose i ka wā o ka digestion.

Tresiba

ʻO Tresiba, i ʻae ʻia ma 2015, kahi mana inoa inoa o ka lāʻau insulin degludec. Hoʻohana ʻia ia e mālama i nā ʻano maʻi diabetes 1 a me ʻelua.

ʻO Tresiba kahi insulina hana lōʻihi e lōʻihi a 42 mau hola. ʻOi aku kēia ma mua o ka insulin maʻamau. Hoʻokomo ʻia hoʻokahi manawa i kēlā me kēia lā.

Basaglar lāua ʻo Toujeo

ʻO Basaglar lāua ʻo Toujeo ʻelua mau ʻano hou o ka glargine insulin. Hoʻohana ʻia lākou e mālama i ka ʻano maʻi ʻelua a me ka maʻi ʻelua, a ʻoki pū ʻia lāua i hoʻokahi manawa i kēlā me kēia lā.

ʻO Basaglar kahi lāʻau insulin lōʻihi lōʻihi i ʻae ʻia i ka makahiki 2015. Ua like ia me kekahi lāʻau lapaʻau glargine insulin i kapa ʻia ʻo Lantus. ʻO Toujeo kahi ʻano ʻoi loa o ka insulin glargine. Ua ʻae ʻia no ka hoʻohana ʻana ma 2015.

Xultophy

Ua ʻae ʻia ʻo Xultophy ma 2016. Hoʻohana wale ʻia ia e mālama i ka maʻi diabetes type 2. Hoʻokomo ʻia ʻo Xultophy i hoʻokahi manawa i kēlā me kēia lā.

Hoʻohui ʻo Xultophy i ka insulin degludec, kahi insulin lōʻihi lōʻihi, a me liraglutide, kahi agonist GLP-1.

ʻO Soliqua

Ua ʻae ʻia ʻo Soliqua i ka makahiki 2016. Hoʻohana wale ʻia ia e mālama i ka maʻi diabetes type 2. Hoʻokomo ʻia hoʻokahi manawa i kēlā me kēia lā.

Hoʻohui ʻo Soliqua i ka lāʻau glargine insulin me lixisenatide, kahi agonist receptor GLP-1.

Ozempic

Ua ʻae ʻia ʻo Ozempic i ka hopena o 2017. Hoʻohana wale ʻia ia e mālama i ka maʻi diabetes type 2. ʻO Ozempic kahi mana inoa inoa o ka agonist GLP-1 i kapa ʻia ʻo semaglutide. Hoʻokomo ʻia hoʻokahi manawa i kēlā me kēia pule.

Adlyxin

Ua ʻae ʻia ʻo Adlyxin ma 2016. Hoʻohana wale ʻia ia e mālama i ka maʻi diabetes type 2. ʻO Adlyxin kahi mana inoa inoa o ka agonist GLP-1 i kapa ʻia ʻo lixisenatide. Hoʻokomo ʻia hoʻokahi manawa i kēlā me kēia lā.

ʻO Ryzodeg

Ua ʻae ʻia ʻo Ryzodeg ma 2016 akā ʻaʻole i loaʻa. Hoʻonohonoho ʻia e hoʻohana ʻia e mālama i nā ʻano diabetes 1 a me nā ʻano ʻelua. Hoʻohui ʻo Ryzodeg i ka insulin degludec me ka insulin aspart. Pono ia e injected i hoʻokahi a ʻelua paha lā i kēlā me kēia lā.

Nā lāʻau diabetes i ka ulu ʻana

Ma waho aʻe o kēia mau lāʻau hou, ke hoʻomohala ʻia nei kekahi mau lāʻau diabetes. Hoʻopili kēia mau lāʻau:

• ʻO oral-Lyn. Hele mai kēia lāʻau lapaʻau inoa inoa ma ke ʻano he spray insulin insulina wikiwiki. Hoʻonohonoho ʻia e mālama i ka maʻi diabetes 1 a me ʻelua.
• Hula 501. Aia i loko o kēia hāmeʻa aerosol kahi insulina wai i manaʻo ʻia e hanu ʻia i ka manawa ʻai. Hoʻonohonoho ʻia e mālama i ka maʻi diabetes 1 a me ʻelua.

Nā lāʻau lapaʻau diabetes maʻamau i hoʻohana mau ʻia

I kēia manawa ua ʻike ʻoe e pili ana i nā lāʻau diabetes hou a me nā wā e hiki mai ana, eia kahi papa inoa o kekahi o nā lāʻau diabetes i hoʻohana pinepine ʻia i kēia manawa. ʻO kekahi o kēia mau lāʻau lapaʻau nā ʻāpana o nā lāʻau hoʻohui hou i helu ʻia ma luna, a ʻo nā lāʻau i hoʻohui ʻia i lalo ma lalo.

Nā lāʻau lapaʻau waha

Hoʻohana pinepine ʻia nā pūʻulu lāʻau i lalo e mālama i ka maʻi diabetes type 2. Hele mai nā mea āpau ma ke ʻano he papa ʻōlelo waha. Hele mai ʻo Metformin ma ke ʻano he hopena waha.

ʻO Biguanides e like me metformin

ʻO Metformin ka lāʻau lapaʻau mua i hoʻohana ʻia e mālama i ka maʻi diabetes type 2. Hana ia ma ka hoʻolohi ʻana i ka hana glucose i kou ake. Hoʻohālikelike ia i nā kino o kou kino i ka insulin. Kōkua kēia i nā kino i ke komo i ka glucose.

Hoʻohui pū ʻia ʻo Metformin me nā lāʻau lapaʻau ʻē aʻe e hōʻemi i ka helu o nā papa e pono ai ʻoe e lawe.

Nā mea kāpae Alpha-glucosidase

Hoʻomaʻalohi a pale paha kēia mau lāʻau i ka haʻihaʻi o nā haʻuki i loko o kou kino. Aia nā Carbohidrat i ka starchy a i ʻole nā ​​meaʻai kō. Hoʻohiʻohi kēia hana i ka lawe ʻana o glucose i kou kahe koko. Eia kekahi laʻana o kēia mau lāʻau:

• acarbose
• miglitol

Dipeptidyl peptidase-4 mea kāohi (DPP-IV nā mea kūpale)

Paʻa kēia mau lāʻau i ka haki ʻana o kekahi mau hormones i kou kino e haʻi i kāu pancreas e hana a hoʻokuʻu i ka insulin. Hoʻomaʻalohi kēia mau lāʻau i kou digestion, kahi e hoʻolohi ai i ka hoʻokuʻu ʻia o ka glucose i loko o kou koko. Eia kekahi laʻana o kēia mau lāʻau:

• ʻalekona
• linagliptin
• saxagliptin
• sitagliptin

ʻO Meglitinides

Hōʻike kēia mau lāʻau i kāu pancreas e hoʻokuʻu i ka insulin. Eia kekahi laʻana o kēia mau lāʻau:

• nateglinide
• repaglinide

Sodium-glucose co-transporter 2 mea kāohi (SGLT2)

Paʻa kēia mau lāʻau i kekahi o ka glucose i kāu ʻōnaehana mai ke komo hou ʻana i kou koko ma o kou puʻupaʻa. Hoʻopau pū lākou i kou kino e hoʻopau i nā glucose hou aʻe ma o kou mimi. Eia kekahi laʻana o kēia mau lāʻau:

• kanalifka
• dapagliflozin
• empagliflozin
• ertugliflozin

Sulfonylureas

Hoʻokumu kēia mau lāʻau i kāu pancreas e hoʻokuʻu i ka nui o ka insulin. Eia kekahi laʻana o kēia mau lāʻau:

• glimepiride
• glipizide
• ʻO Glyburide

ʻO Thiazolidinediones

Hana kēia mau lāʻau i nā mea i loko o kou kino e maʻalahi i ka insulin. Kōkua kēia i kou kino e hoʻohana hou i ka glucose i kou koko. Eia kekahi laʻana o kēia mau lāʻau:

• pioglitazone
• rosiglitazone

Hoʻohui lāʻau

Ma waho aʻe o nā mea hou i helu ʻia ma luna, ua loaʻa kekahi mau lāʻau hoʻohui no kekahi manawa. ʻO nā lāʻau i hoʻohui pū ʻia me nā mea penei:

• Pālua he papa e hoʻohui i ka pioglitazone me ka glimepiride.
• Janumet he papa e hoʻohui i ka sitagliptin me ka metformin.
• ʻO kahi lāʻau laulaha maʻamau e hele mai e like me ka hoʻopili ʻana o ka papa metformin me glipizide.
• Nā lāʻau pioglitazone a rosiglitazone loaʻa kēlā me kēia i ka papa papa i ka hui pū ʻia metformin.

Nā lāʻau hoʻōki

ʻO nā papa aʻe o nā lāʻau i hiki mai i nā ʻano hana i hoʻokomo ʻia.

Insulina

Hana ka insulin ʻinikua ma ke ʻano he pani no ka insulina a kou kino e hana ʻole ai hoʻohana hiki ʻole ai. Hiki ke hoʻohana ʻia e mālama i ka maʻi diabetes type 1 a i ʻole type 2.

Loaʻa nā ʻano like ʻole o ka insulin. Hana wikiwiki kekahi ʻano. Kōkua kēia mau ʻano i ke kaohi ʻana i kāu pae kō glucose i ka manawa pāʻina. Hana nā ʻano ʻē aʻe i kahi manawa lōʻihi. Mālama kēia mau ʻano i kou pae kō glucose i loko o ke ao a me ka pō.

ʻO kekahi ʻano o ka insulin me:

• insulin aspart
• degludec insulina
• glargine insulin

Amylin analogue

Lawe ʻia ka amylin analogue i kapa ʻia ʻo pramlintide ma mua o ka pāʻina ʻana. Kōkua ia e hōʻemi i ka nui o ka insulin āu e pono ai. Hoʻohana ʻia ia e mālama i ka ʻano ʻelua a me ka maʻi kōkō ʻelua.

Glucagon-like peptide-1 receptor agonists (GLP-1 agonists)

Kōkua kēia mau lāʻau i kāu pancreas e hoʻokuʻu i ka nui o ka insulin ke kiʻekiʻe ke kiʻekiʻe o kāu glucose. Hoʻoiho lākou i ka lawe ʻana o ka glucose i ka wā o ka digestion. Hoʻohana ʻia kēia mau lāʻau e mālama i ka maʻi diabetes type 2 wale nō.

Eia kekahi laʻana o kēia mau lāʻau:

• ʻalbutide
• dulaglutide
• exenatide
• mele aloha
• ʻaʻano semaglutide

Nā mea e noʻonoʻo ai i ke koho ʻana i kahi lāʻau

ʻOiai ka nui o nā lāʻau diabetes i kūpono ma ka mākeke no nā makahiki, hiki i nā lāʻau hou ke hāʻawi i nā pono i loaʻa ʻole me nā lāʻau i hoʻohana pinepine ʻia.

E noʻonoʻo, ʻaʻole paha mākou e ʻike e pili ana i nā hopena āpau a me nā pilina o nā lāʻau hou. Eia kekahi, ʻoi aku ke kumukūʻai o nā lāʻau hou aku ma mua o nā lāʻau kahiko, a i ʻole ʻaʻole uhi ʻia e ka hapa nui o nā hoʻolālā ʻinikua. Hoʻohui ʻia, makemake paha kāu papa ʻinikua i kekahi mau lāʻau ma mua o nā mea ʻē aʻe, a koi paha lākou iā ʻoe e hana i ka hoʻāʻo ʻana o nā lāʻau ʻelemakule, ʻoi aku ka liʻiliʻi ma mua o ka uhi ʻana i nā lāʻau hou a ʻoi aku ka maikaʻi.

He mea nui e kamaʻilio me kāu kauka inā ʻoe e noʻonoʻo nei i nā koho lāʻau diabetes hou. E kūkākūkā i kāu mōʻaukala piha me kāu kauka, a me nā lāʻau a me nā mea hoʻopihapiha āu e lawe ai. Hiki iā ʻoe a me kāu kauka ke hoʻoholo i nā lāʻau hou, inā paha, kūpono paha iā ʻoe.